|Articles|August 3, 2022
H1 and Lokavant Announce Partnership
Advertisement
H1 and Lokavant announced a data-and-analytics collaboration to bring enhanced automated intelligence to drug development. As part of the bi-directional partnership, Lokavant will provide performance data on global trial sites and principal investigators to supplement H1’s existing Trial Landscape clinical trial repository.
Read more about the new partnership
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The AI Churn Trap in Life Sciences and How to Break It
2
ACT Brief: Execution Failures and Upstream Origins, European Data Governance Reshaping CROs, and Phase-Dependent Trial Competition
3
Real-World Evidence in Transition: CRO Adaptation to the European Health Data Space Framework
4
ACT Brief: Sponsor Oversight Capability Gaps, Community-Embedded Trial Partnerships, and Trialblazer Timeline Realism
5